Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yann Meslier"'
Autor:
Sébastien Lacroix-Desmazes, Yann Meslier, Srinivas V. Kaveri, Sébastien André, Maud Teyssandier
Publikováno v:
Immunology. 131:549-555
Replacement therapy with exogenous factor VIII (FVIII) to treat haemorrhages or used in prophylaxis induces inhibitory anti-FVIII immunoglobulin G (IgG) in some patients with haemophilia A. Therapeutic strategies to prevent the onset of the deleterio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9665dccf115055d003d53c1ec6e0f654
https://doi.org/10.1111/j.1365-2567.2010.03327.x
https://doi.org/10.1111/j.1365-2567.2010.03327.x
Autor:
Sune Justesen, Maxime Lecerf, Sébastien Lacroix-Desmazes, Roberto Mallone, Jordan D. Dimitrov, David W. Scott, Yann Meslier, Valérie Gouilleux-Gruart, Srinivas V. Kaveri, Slobodan Culina, Bagirath Gangadharan, Christophe Arnoult, Nimesh Gupta, Benoît L. Salomon, Sandrine Delignat
Publikováno v:
Science Translational Medicine
Science Translational Medicine, American Association for the Advancement of Science, 2015, 7 (275), pp.275ra21-275ra21. ⟨10.1126/scitranslmed.aaa1957⟩
Science Translational Medicine, 2015, 7 (275), pp.275ra21-275ra21. ⟨10.1126/scitranslmed.aaa1957⟩
Science Translational Medicine, American Association for the Advancement of Science, 2015, 7 (275), pp.275ra21-275ra21. ⟨10.1126/scitranslmed.aaa1957⟩
Science Translational Medicine, 2015, 7 (275), pp.275ra21-275ra21. ⟨10.1126/scitranslmed.aaa1957⟩
International audience; Central tolerance plays a key role in modulating immune responses to self and exogenous antigens. The absence of self-antigen expression, as in patients with genetic deficiencies, prevents the development of antigen-specific i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75954b3478b0a22dcba32e07781c3237
https://doi.org/10.1126/scitranslmed.aaa1957
https://doi.org/10.1126/scitranslmed.aaa1957
Autor:
Yann Meslier, Srini V. Kaveri, Sébastien André, Jordan D. Dimitrov, Sébastien Lacroix-Desmazes, Jagadeesh Bayry, Sandrine Delignat
Publikováno v:
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis, Wiley, 2011, 9 (4), pp.719-728. ⟨10.1111/j.1538-7836.2011.04200.x⟩
Journal of Thrombosis and Haemostasis, 2011, 9 (4), pp.719-728. ⟨10.1111/j.1538-7836.2011.04200.x⟩
Journal of Thrombosis and Haemostasis, Wiley, 2011, 9 (4), pp.719-728. ⟨10.1111/j.1538-7836.2011.04200.x⟩
Journal of Thrombosis and Haemostasis, 2011, 9 (4), pp.719-728. ⟨10.1111/j.1538-7836.2011.04200.x⟩
Summary. Background: Replacement therapy with exogenous factor VIII to treat hemorrhages induces inhibitory anti-FVIII antibodies in up to 30% of patients with hemophilia A. Current approaches to eradicate FVIII inhibitors using high-dose FVIII injec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3738d549887d9f97f133d12bfb869b07
https://www.hal.inserm.fr/inserm-02455569
https://www.hal.inserm.fr/inserm-02455569
Autor:
Yann Meslier, Sébastien Lacroix-Desmazes, Jordan D. Dimitrov, Yohann Repessé, Sébastien André, Suryasarathi Dasgupta, Srinivas V. Kaveri
Publikováno v:
Clinical reviews in allergyimmunology. 37(2)
A large proportion of hemophilia A patients who receive replacement therapy, develop an immune response toward the infused factor VIII (FVIII). In this review, we discuss recent progress in several aspects of the anti-FVIII immune response, focusing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91ebed2d46b26ae21a53cb02cf1cdaac
https://pubmed.ncbi.nlm.nih.gov/19165635
https://pubmed.ncbi.nlm.nih.gov/19165635
Autor:
Maud Teyssandier, Sébastien André, Ana-Maria Navarrete, Srini V. Kaveri, Yann Meslier, Frédéric Triebel, Sandrine Delignat, Sébastien Lacroix-Desmazes, Jagadeesh Bayry
Publikováno v:
Arthritis & Rheumatism. 60:2848-2849
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0f204c7b1c94a160425686f27d7774b
https://doi.org/10.1002/art.24784
https://doi.org/10.1002/art.24784